IRIDEX Corp (NASDAQ:IRIX)

9.01
Delayed Data
As of 11:28am ET
 +0.076 / +0.85%
Today’s Change
6.41
Today|||52-Week Range
11.28
+4.72%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$89.6M

Company Description

IRIDEX Corp. provides therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation including laser probes, and are used in the treatment of serious eye diseases, including the three leading causes of irreversible blindness: diabetic retinopathy, glaucoma and age-related macular degeneration. The company's ophthalmology products are also often used in vitrectomy procedures, which are generally performed in the operating room and require a consumable single use intraocular laser probe to deliver light to the back of the eye together with other instrumentation. IRIDEX was founded by Eduardo Arias, Theodore A. Boutacoff and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Contact Information

IRIDEX Corp.
1212 Terra Bella Avenue
Mountain View California 94043
P:(650) 940-4700
Investor Relations:
(650) 605-8716

Employees

Shareholders

Other institutional53.27%
Mutual fund holders5.30%
Individual stakeholders39.75%

Top Executives

William M. MooreChairman, President & Chief Executive Officer
James H. MackanessCOO, CFO & Head-Investor Relations
Kenneth A. PeartreeVice President-Research & Development
Paul H. HardimanVice President-Regulatory & Compliance
Ronald T. SteckelVice President-Operations

To view my watchlist

Not a member yet?

Sign up now for a free account